Today is World Malaria Day, and we’ve got good news about the fight against a disease that still kills about 650,000 people, mainly young African children, every year. Earlier this month, we told you about the work of the PATH Malaria Vaccine Initiative and our affiliate, OneWorld Health. Today, Dr. Kent Campbell, director of PATH’s Malaria Control and Evaluation Partnership in Africa (MACEPA) writes about the importance of investing in malaria work. You can learn more on our website about the work on malaria control.
by Dr. Kent Campbell
The world has made enormous strides in fighting malaria in the past decade. The lives of many children have been saved, families are healthier and more financially secure, and the malaria parasite is on the run. Strong country leadership and a united Roll Back Malaria partnership have been critical to these accomplishments.
The combination of multilateral and bilateral funding to countries has provided the critical support for program implementation. And best of all, the tools to fight the disease are inexpensive and easy to deploy. The bottom line? Malaria control is one of the best value-for-money public health investments in generations, as illustrated in this malaria investment infographic (3 MB PDF).
World Malaria Day is this week, and we’ve reached a critical moment in history. The current economic climate is challenging, and the successes to date are fragile. We must choose to keep investing in shrinking the malaria map, and not let commitments subside and allow the disease to resurge. Millions of lives depend on the strong support needed to continue to make progress towards the attainable goal—a world free from malaria.